Interim Report from the Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients with Chronic Obstructive Pulmonary Disease (PROMISE) Evaluation

This brief report presents six-month interim results from a twelve-month pragmatic program evaluation investigating the impact of the NuvoAir Home Service (NAHS) in COPD patients. Patients in the evaluation group received remote monitoring and personalized chronic care management through the NAHS platform. Results: 190 NAHS participants compared to 570 propensity matched controls: All-cause hospitalizations 31% Decrease (p = 0.13) All-cause days hospitalized 52% Decrease (p = 0.05) All-cause readmissions 45% Decrease (p = 0.40) All-cause ED visits 5% Decrease (p = 0.71) All-cause outpatient office visits 9% Increase (p = 0.16) Avoidable hospitalizations 42% Decrease (p = 0.05) Avoidable days hospitalized 43% Increase (p = 0.15) Avoidable readmissions 77% Decrease (p = 0.06) Avoidable ED visits No Change (p = 0.99) Avoidable outpatient office visits 12% Increase (p = 0.09) These interim data indicate that NuvoAir Home Service had a clinically significant positive impact on hospital utilization, no change in ED utilization, and a small increase in outpatient visits, though not all preliminary data met statistical significance.